These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27913193)

  • 1. Neuropeptide Y, resilience, and PTSD therapeutics.
    Kautz M; Charney DS; Murrough JW
    Neurosci Lett; 2017 May; 649():164-169. PubMed ID: 27913193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.
    Cohen H; Liu T; Kozlovsky N; Kaplan Z; Zohar J; Mathé AA
    Neuropsychopharmacology; 2012 Jan; 37(2):350-63. PubMed ID: 21976046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): A translational update.
    Schmeltzer SN; Herman JP; Sah R
    Exp Neurol; 2016 Oct; 284(Pt B):196-210. PubMed ID: 27377319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide S in the basolateral amygdala mediates an adaptive behavioral stress response in a rat model of posttraumatic stress disorder by increasing the expression of BDNF and the neuropeptide YY1 receptor.
    Cohen H; Vainer E; Zeev K; Zohar J; Mathé AA
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):159-170. PubMed ID: 29157796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.
    Corder KM; Li Q; Cortes MA; Bartley AF; Davis TR; Dobrunz LE
    Neuropeptides; 2020 Feb; 79():101979. PubMed ID: 31708112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y and posttraumatic stress disorder.
    Sah R; Geracioti TD
    Mol Psychiatry; 2013 Jun; 18(6):646-55. PubMed ID: 22801411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder.
    Sabban EL; Alaluf LG; Serova LI
    Neuropeptides; 2016 Apr; 56():19-24. PubMed ID: 26617395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuropeptide Y in accident survivors with depression or posttraumatic stress disorder.
    Nishi D; Hashimoto K; Noguchi H; Matsuoka Y
    Neurosci Res; 2014 Jun; 83():8-12. PubMed ID: 24709369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.
    Serova LI; Tillinger A; Alaluf LG; Laukova M; Keegan K; Sabban EL
    Neuroscience; 2013 Apr; 236():298-312. PubMed ID: 23376740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular responses to intranasal neuropeptide Y in single prolonged stress rodent model of post-traumatic stress disorder.
    Camp R; Stier CT; Serova LI; McCloskey J; Edwards JG; Reyes-Zaragoza M; Sabban EL
    Neuropeptides; 2018 Feb; 67():87-94. PubMed ID: 29169656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of Intranasal Neuropeptide Y (NPY) and/or Melanocortin 4 Receptor (MC4R) Antagonists for Preventing or Treating PTSD.
    Sabban EL; Serova LI
    Mil Med; 2018 Mar; 183(suppl_1):408-412. PubMed ID: 29635611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder.
    Hendriksen H; Bink DI; Daniels EG; Pandit R; Piriou C; Slieker R; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Sep; 63(4):733-42. PubMed ID: 22659471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model.
    Serova LI; Laukova M; Alaluf LG; Pucillo L; Sabban EL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):142-7. PubMed ID: 24326087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping.
    Yehuda R; Brand S; Yang RK
    Biol Psychiatry; 2006 Apr; 59(7):660-3. PubMed ID: 16325152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NPY receptor subtype 1 by [D-His
    Nwokafor C; Serova LI; Nahvi RJ; McCloskey J; Sabban EL
    Neuropeptides; 2020 Apr; 80():102001. PubMed ID: 31916978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Enrichment Reduces Anxiety by Differentially Activating Serotonergic and Neuropeptide Y (NPY)-Ergic System in Indian Field Mouse (Mus booduga): An Animal Model of Post-Traumatic Stress Disorder.
    Ragu Varman D; Rajan KE
    PLoS One; 2015; 10(5):e0127945. PubMed ID: 26016844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive treatment with brexpiprazole and escitalopram reduces behavioral stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms.
    Cohen H; Zohar J; Kaplan Z; Arnt J
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):63-74. PubMed ID: 29224968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder.
    Sayed S; Van Dam NT; Horn SR; Kautz MM; Parides M; Costi S; Collins KA; Iacoviello B; Iosifescu DV; Mathé AA; Southwick SM; Feder A; Charney DS; Murrough JW
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):3-11. PubMed ID: 29186416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefits of intranasal neuropeptide Y include sustained extinction of fear memory.
    Sabban EL; Serova L; Nahvi RJ; Liu X
    J Neuroendocrinol; 2023 Nov; 35(11):e13279. PubMed ID: 37157881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific involvement of interneuron subpopulations in trauma-related pathology and resilience.
    Regev-Tsur S; Demiray YE; Tripathi K; Stork O; Richter-Levin G; Albrecht A
    Neurobiol Dis; 2020 Sep; 143():104974. PubMed ID: 32561495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.